Have you been paying attention to shares of Artivion (AORT) ? Shares have been on the move with the stock up 9.6% over the past month. The stock hit a new 52-week high of $21.82 in the previous session. Artivion has gained 18.3% since the start of the year compared to the 8.2% move for the Zacks Medical sector and the 9.4% return for the Zacks Medical - Instruments industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings c ...

As many know, small-caps’ volatile nature can sometimes turn investors away.However, many small-cap stocks turn out to be big winners in the long run, and they typically have fewer eyes on them, providing investors an opportunity to get in "early" before the crowd.For those seeking exposure to small-caps, three stocks – EZCORP (EZPW) , Artivion (AORT) , and QuickLogic (QUIK) – could all be considered.All three sport a favorable Zacks Rank, indicating optimism among analysts. Let’s take a closer look at each ...

The Medical Instruments industry is highly fragmented, with participants engaged in research and development (R&D) in therapeutic areas. The industry has been witnessing a gradual transition from remote healthcare and contactless services during the pandemic to its original space of point-of-care testing, heavy as well as minimally invasive implants, elective procedures, and so on and so forth.The medical instruments space has been benefiting from the ongoing merger and acquisition trend. The smaller and mi ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Artivion (AORT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.Artivion is a member of our Medical group, which includes 1066 different companies and currently sits at #4 in the Zacks Sector Rank. The Zacks Sector Rank gauges th ...

ATLANTA, March 6, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 34th Annual Healthcare MedTech & Services Conference. The Company's virtual fireside chat is scheduled to begin at 10:40 a.m. ET on March 13, 2023. A live webcast of the virtual fireside chat will be accessible through Artivion's website, www.artivion.com, on the Investors page. An archived ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13165 ARTIVION, INC. (Exact name of registrant as specified in its charter) Delaware 59-2417093 (State or other jurisdiction of incorpo ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Artivion (AORT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.Artivion is one of 1067 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Ran ...

Shares of Artivion (AORT) have been strong performers lately, with the stock up 15.9% over the past month. The stock hit a new 52-week high of $19.63 in the previous session. Artivion has gained 9.5% since the start of the year compared to the 6% move for the Zacks Medical sector and the 4.4% return for the Zacks Medical - Instruments industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last ...

Artivion (AORT) closed the last trading session at $18.70, gaining 6.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $24.44 indicates a 30.7% upside potential.The average comprises four short-term price targets ranging from a low of $22 to a high of $25.75, with a standard deviation of $1.66. While the lowest estimate indicates an increase of 17.7% from the current price level, ...

Artivion, Inc. (NYSE:AORT) Q4 2023 Earnings Conference Call February 15, 2024 4:30 PM ET Company Participants Laine Morgan - IR, Gilmartin Group Pat Mackin - CEO Lance Berry - CFO Conference Call Participants John McAulay - Stifel Mike Matson - Needham Suraj Kalia - Oppenheimer Jeffrey Cohen - Ladenburg Thalmann Nelson Cox - Lake Street Capital Operator Greetings, and welcome to the Artivion Fourth Quarter and Year-End 2023 Financial Conference Call. At this time, all participants are in a listen-only mode. ...